Skip to main content
Top
Published in:

Open Access 06-01-2025 | Graves Disease | Case Report

Graves’ disease diagnosed nearly six months after microwave ablation of benign thyroid nodules: a case report

Authors: Yunru Gu, Rui Chen, Mingming Chen, Xiaohong Jiang, Long Wang, Xiaolin Huang

Published in: BMC Endocrine Disorders | Issue 1/2025

Login to get access

Abstract

Background

Microwave ablation is a new, minimally invasive technique for the treatment of thyroid nodules. Hyperthyroidism due to destructive thyroiditis is a known risk of microwave ablation, though it occurs in only a minority of cases. We report a rare case of a patient diagnosed with Graves’ disease nearly six months after undergoing microwave ablation of a thyroid nodule.

Case presentation

On July 31, 2022, a 43-year-old male patient presented to our hospital with symptoms of pyrexia, excessive sweating, and palpitations lasting for 15 days. History inquiry revealed that the patient had undergone microwave ablation of right-sided thyroid nodule nearly five months ago at another hospital. The patient’s thyroid ultrasound suggested bilateral diffuse thyroid lesions, with a moderately echogenic mass observed on the right side of the thyroid gland, potentially indicative of thyroid nodule ablation. The patient had elevated serum thyroid hormone levels, decreased thyroid-stimulating hormone levels and positive associated thyroid antibodies. To control the symptoms of hyperthyroidism, the patient opted for oral antithyroid medication, and thyroid hormonal levels returned to normal after 3 months of treatment. The patient is now under regular follow-up.

Conclusions

In this case, we presented the onset of Graves’ disease following microwave ablation in a patient with subclinical thyroid autoimmunity. While the causal relationship between microwave ablation and Graves’ disease remains unproven, this case suggests that preexisting autoimmune thyroid conditions may increase susceptibility to postoperative thyroid dysfunction. Procedural factors, such as thermal injury to surrounding tissues and potential involvement of the autonomic nervous system, are also potential contributors to the development of Graves’ disease following microwave ablation.
Literature
1.
go back to reference Xia B, Yu B, Wang X, Ma Y, Liu F, Gong Y, et al. Conspicuousness and recurrence related factors of ultrasound-guided microwave ablation in the treatment of benign thyroid nodules. BMC Surg. 2021;21(1):317.CrossRefPubMedPubMedCentral Xia B, Yu B, Wang X, Ma Y, Liu F, Gong Y, et al. Conspicuousness and recurrence related factors of ultrasound-guided microwave ablation in the treatment of benign thyroid nodules. BMC Surg. 2021;21(1):317.CrossRefPubMedPubMedCentral
2.
go back to reference Lim JY, Kuo JH. Thyroid nodule Radiofrequency ablation: complications and clinical follow up. Tech Vasc Interv Radiol. 2022;25(2):100824.CrossRefPubMed Lim JY, Kuo JH. Thyroid nodule Radiofrequency ablation: complications and clinical follow up. Tech Vasc Interv Radiol. 2022;25(2):100824.CrossRefPubMed
3.
4.
go back to reference Zhao ZL, Wei Y, Peng LL, Li Y, Lu NC, Yu MA. Recurrent laryngeal nerve Injury in Thermal ablation of thyroid nodules-risk factors and cause analysis. J Clin Endocrinol Metab. 2022;107(7):e2930–7.CrossRefPubMed Zhao ZL, Wei Y, Peng LL, Li Y, Lu NC, Yu MA. Recurrent laryngeal nerve Injury in Thermal ablation of thyroid nodules-risk factors and cause analysis. J Clin Endocrinol Metab. 2022;107(7):e2930–7.CrossRefPubMed
5.
go back to reference Wang N, Zheng B, Wu T, Tan L, Lian Y, Ma Y, et al. Thyroid dysfunction following radiofrequency ablation for benign thyroid nodules: more likely to occur within one-week and in high-risk population. Int J Hyperth. 2021;38(1):1060–8.CrossRef Wang N, Zheng B, Wu T, Tan L, Lian Y, Ma Y, et al. Thyroid dysfunction following radiofrequency ablation for benign thyroid nodules: more likely to occur within one-week and in high-risk population. Int J Hyperth. 2021;38(1):1060–8.CrossRef
6.
go back to reference World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. 3rd ed. Geneva: World Health Organization; 2007. World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. 3rd ed. Geneva: World Health Organization; 2007.
7.
go back to reference Cui T, Jin C, Jiao D, Teng D, Sui G. Safety and efficacy of microwave ablation for benign thyroid nodules and papillary thyroid microcarcinomas: A systematic review and meta-analysis. Eur J Radiol. 2019;118:58–64. Cui T, Jin C, Jiao D, Teng D, Sui G. Safety and efficacy of microwave ablation for benign thyroid nodules and papillary thyroid microcarcinomas: A systematic review and meta-analysis. Eur J Radiol. 2019;118:58–64.
8.
go back to reference Han ZY, Dou JP, Zheng L, Che Y, Yu MA, Wang SR, et al. Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study. Eur Radiol. 2023;33(11):7942–51.CrossRefPubMed Han ZY, Dou JP, Zheng L, Che Y, Yu MA, Wang SR, et al. Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study. Eur Radiol. 2023;33(11):7942–51.CrossRefPubMed
9.
go back to reference Du JR, Li WH, Quan CH, Wang H, Teng DK. Long-term outcome of microwave ablation for benign thyroid nodules: over 48-month follow-up study. Front Endocrinol (Lausanne). 2022;13:941137.CrossRefPubMed Du JR, Li WH, Quan CH, Wang H, Teng DK. Long-term outcome of microwave ablation for benign thyroid nodules: over 48-month follow-up study. Front Endocrinol (Lausanne). 2022;13:941137.CrossRefPubMed
10.
go back to reference Liu SY, Guo WH, Yang B, Li YF, Huang XY, Wang XQ, et al. Comparison of stress response following microwave ablation and surgical resection of benign thyroid nodules. Endocrine. 2019;65(1):138–43.CrossRefPubMed Liu SY, Guo WH, Yang B, Li YF, Huang XY, Wang XQ, et al. Comparison of stress response following microwave ablation and surgical resection of benign thyroid nodules. Endocrine. 2019;65(1):138–43.CrossRefPubMed
11.
go back to reference Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 2023;11(4):282–98.CrossRefPubMed Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 2023;11(4):282–98.CrossRefPubMed
12.
13.
go back to reference Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, et al. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101387.CrossRefPubMed Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, et al. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101387.CrossRefPubMed
14.
go back to reference Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I, et al. Graves’ disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101388.CrossRefPubMed Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I, et al. Graves’ disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101388.CrossRefPubMed
15.
go back to reference Liu H, Liu H, Liu C, Shang M, Wei T, Yin P. Gut microbiome and the role of metabolites in the study of Graves’ Disease. Front Mol Biosci. 2022;9:841223.CrossRefPubMedPubMedCentral Liu H, Liu H, Liu C, Shang M, Wei T, Yin P. Gut microbiome and the role of metabolites in the study of Graves’ Disease. Front Mol Biosci. 2022;9:841223.CrossRefPubMedPubMedCentral
16.
go back to reference Erturk MS, Cekic B, Celik M, Ucar H. Microwave ablation of symptomatic benign thyroid nodules: short- and long-term effects on thyroid function tests, thyroglobulin and thyroid autoantibodies. Clin Endocrinol (Oxf). 2021;94(4):677–83.CrossRefPubMed Erturk MS, Cekic B, Celik M, Ucar H. Microwave ablation of symptomatic benign thyroid nodules: short- and long-term effects on thyroid function tests, thyroglobulin and thyroid autoantibodies. Clin Endocrinol (Oxf). 2021;94(4):677–83.CrossRefPubMed
17.
go back to reference Fei Y, Qiu Y, Huang D, Xing Z, Li Z, Su A, Zhu J. Effects of energy-based ablation on thyroid function in treating benign thyroid nodules: a systematic review and meta-analysis. Int J Hyperth. 2020;37(1):1090–102.CrossRef Fei Y, Qiu Y, Huang D, Xing Z, Li Z, Su A, Zhu J. Effects of energy-based ablation on thyroid function in treating benign thyroid nodules: a systematic review and meta-analysis. Int J Hyperth. 2020;37(1):1090–102.CrossRef
18.
go back to reference Ushakov AV. Minor hyperthyroidism with normal levels of thyroid-stimulating hormone receptor antibodies: a case report. J Med Life. 2024;17(2):236–8.CrossRefPubMedPubMedCentral Ushakov AV. Minor hyperthyroidism with normal levels of thyroid-stimulating hormone receptor antibodies: a case report. J Med Life. 2024;17(2):236–8.CrossRefPubMedPubMedCentral
19.
go back to reference Ushakov A. Case of Graves’ disease recovery. J Clin Transl Endocrinol Case Rep. 2023;100139. Ushakov A. Case of Graves’ disease recovery. J Clin Transl Endocrinol Case Rep. 2023;100139.
Metadata
Title
Graves’ disease diagnosed nearly six months after microwave ablation of benign thyroid nodules: a case report
Authors
Yunru Gu
Rui Chen
Mingming Chen
Xiaohong Jiang
Long Wang
Xiaolin Huang
Publication date
06-01-2025
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2025
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01824-w

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more